Glenmark Pharma launches triple-drug FDC of Teneligliptin + Dapagliflozin + Metformin in India
Express Pharma
OCTOBER 18, 2023
It must be taken once daily, under prescription, to improve glycemic control in patients with Type 2 diabetes. According to IQVIA sales data for the 12‐month period ending August 2023 (MAT August 2023), the market for oral anti‐diabetic drugs in India is estimated to be Rs 12,522 crores, with an annual growth of 6.5
Let's personalize your content